Lyka Labs Limited: NCLT Approves Merger Scheme with Lyka Exports Limited
NCLT Ahmedabad has approved the amalgamation scheme between Lyka Exports Limited and Lyka Labs Limited. The appointed date for the merger is April 01, 2022. Lyka Labs will now file the necessary forms with the Registrar of Companies.
The approval of a merger scheme is a material corporate action that can significantly impact the company's structure, operations, and future prospects.
The NCLT's approval of the amalgamation scheme is a positive development for Lyka Labs Limited, marking a significant step towards the merger completion.
Lyka Labs Limited has announced that the Hon’ble National Company Law Tribunal (NCLT), Ahmedabad Bench, has approved the scheme of amalgamation between Lyka Exports Limited (Transferor Company) and Lyka Labs Limited (Transferee Company) on March 16, 2026. This approval, granted under Sections 230 to 232 of the Companies Act, 2013, follows a previous intimation dated February 20, 2026, regarding the scheme, which was listed under Company Petition CP (CAA) No. 58 of 2024.
The appointed date for this merger scheme is April 01, 2022. The company is currently undertaking the necessary procedural steps, including filing the e-form INC-28 along with the copy of the NCLT order and the scheme with the Registrar of Companies within 30 days of receiving the order.
The NCLT's approval signifies a significant step in the amalgamation process between the two entities.
What to do with a filing like this
Lyka Labs Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lyka Labs Limited. Read the original for the full detail.